Finance

Lists
Outlook: 75.0% bullish·0.0% bearish
Go to analysis
XENE:NASDAQ
Xenon Pharmaceuticals Inc
၃၅.၉၁ US$
-၁.၈၀%
(-၀.၆၆) 1D
အောက် ၇, GMT-၄ ၀၉:၅၄:၅၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XENE...
Open
၃၆.၁၉ US$
High
၃၆.၄၀ US$
Low
၃၅.၇၈ US$
Mkt. cap
၃၅၁.၉၂ ဋေ
Avg. vol.
၂.၀၈ သန်း
Volume
၁.၀၂ သိန်း
52-wk high
၇၂.၆၆ US$
52-wk low
၃၅.၇၅ US$
EPS
-၄.၇၄ US$
Beta
၀.၆၀
Shares outstanding
၉.၆၈ ကုဋေ
No. of employees
၃၆၄
Open
၃၆.၁၉ US$
High
၃၆.၄၀ US$
Low
၃၅.၇၈ US$
Mkt. cap
၃၅၁.၉၂ ဋေ
Avg. vol.
၂.၀၈ သန်း
Volume
၁.၀၂ သိန်း
52-wk high
၇၂.၆၆ US$
52-wk low
၃၅.၇၅ US$
EPS
-၄.၇၄ US$
Beta
၀.၆၀
Shares outstanding
၉.၆၈ ကုဋေ
No. of employees
၃၆၄
News stories
From web sources and news partners
Investing.com Canada
Investing.com Canada
·
ပြီးခဲ့သည့် ၂၁ နာရီ
Xenon Pharmaceuticals stock hits 52-week low at 36.06 USD By Investing.com
GuruFocus
GuruFocus
·
ပြီးခဲ့သည့် ၁ ရက်
XENE Assumed by Guggenheim -- Buy Rating Assigned with Price Tar
About Xenon Pharmaceuticals Inc
CEO-
Employees၃၆၄
Founded၁၉၉၆
Headquartersဗန်ကူးဗားမြို့, ဗြိတိသျှ ကိုလံဘီယာ ပြည်နယ်, ကနေဒါ
Sector-
Analyst ratings
Based on 16 analysts giving stock ratings to XENE in the past 3 months
Strong buy
Buy
15
Hold
1
Sell
0
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for XENE in the last 3 months.
Highest
Current ၃၅.၉၁ US$
၉၀.၀၀ US$ (+၁၅၀.၆၃%)
Average
၇၀.၀၀ US$ (+၉၄.၉၃%)
Lowest
၄၆.၀၀ US$ (+၂၈.၁၀%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Guggenheim
Buy
Initiated
၇၃.၀၀ US$
+၁၀၃.၃%
10/05/2026
Brian Abrahams
RBC Capital
Buy
Maintained
၇၀.၀၀ US$
+၉၄.၉%
10/01/2026
David Martin PhD
Bloom Burton
Buy
Maintained
၇၁.၀၀ US$
+၉၇.၇%
09/21/2026
Tessa Romero
J.P. Morgan
Buy
Reiterated
၈၂.၀၀ US$
+၁၂၈.၃%
09/19/2026
Jason Gerberry
Bank of America Securities
Buy
Maintained
-
-
09/18/2026
Paul Matteis
Stifel Nicolaus
Buy
Maintained
-
-
09/18/2026
Paul Choi
Goldman Sachs
Buy
Maintained
၇၅.၀၀ US$
+၁၀၈.၉%
09/17/2026
Laura Chico
Wedbush
Buy
Maintained
၅၅.၀၀ US$
+၅၃.၂%
09/18/2026
Joseph Thome
TD Cowen
Buy
Maintained
-
-
09/18/2026
Brian Skorney
Robert W. Baird
Buy
Maintained
၉၀.၀၀ US$
+၁၅၀.၆%
09/18/2026
Benjamin Burnett
Wells Fargo
Buy
Reiterated
၆၄.၀၀ US$
+၇၈.၂%
09/18/2026
Serge Belanger
Needham
Buy
Maintained
၆၀.၀၀ US$
+၆၇.၁%
09/18/2026
Douglas Tsao
H.C. Wainwright
Buy
Maintained
၇၄.၀၀ US$
+၁၀၆.၁%
09/18/2026
David Hoang
Deutsche Bank
Hold
Downgraded
၄၆.၀၀ US$
+၂၈.၁%
09/18/2026
Myles Minter
William Blair
Buy
Maintained
-
-
09/18/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
၈၀.၀၀ US$
+၁၂၂.၈%
08/07/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
၉၀.၀၀ US$
+၁၅၀.၆%
08/06/2026
Unknown Analyst
Leerink Partners
Buy
Maintained
၆၃.၀၀ US$
+၇၅.၄%
06/22/2026
Andrew Tsai
Jefferies
Buy
Reiterated
၁၀၀.၀၀ US$
+၁၇၈.၅%
03/09/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
၅၅.၀၀ US$
+၅၃.၂%
02/26/2026
Rudy Li
Wolfe Research
Buy
Initiated
၆၀.၀၀ US$
+၆၇.၁%
02/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
၇.၇၁ ကုဋေ
၈.၇၇ ကုဋေ
၈.၈၅ ကုဋေ
၉.၉၂ ကုဋေ
Cost of revenue
၇.၇၁ ကုဋေ
၈.၇၇ ကုဋေ
၈.၈၅ ကုဋေ
၉.၉၂ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁.၉၃ ကုဋေ
၂.၂၁ ကုဋေ
၂.၃၈ ကုဋေ
၂.၃၉ ကုဋေ
Operating expense
၁.၉၃ ကုဋေ
၂.၂၁ ကုဋေ
၂.၃၈ ကုဋေ
၂.၃၉ ကုဋေ
Total operating expenses
၉.၆၃ ကုဋေ
၁၀.၉၈ ကုဋေ
၁၁.၂၃ ကုဋေ
၁၂.၃၂ ကုဋေ
Operating income
-၉.၆၃ ကုဋေ
-၁၀.၉၈ ကုဋေ
-၁၁.၂၃ ကုဋေ
-၁၂.၃၂ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
-၉.၀၂ ကုဋေ
-၁၀.၄၇ ကုဋေ
-၁၀.၄၉ ကုဋေ
-၁၁.၁၃ ကုဋေ
EBT excluding unusual items
-၉.၀၂ ကုဋေ
-၁၀.၄၇ ကုဋေ
-၁၀.၄၉ ကုဋေ
-၁၁.၁၃ ကုဋေ
Income tax expense
၆.၇၇ သိန်း
၅.၃၈ သိန်း
-၂.၅၇ သန်း
-၅.၈၅ သိန်း
Effective tax rate
-၀.၇၅%
-၀.၅၁%
၂.၄၅%
၀.၅၃%
Other operating expenses
-
-
-
-
Net income
-၉.၀၉ ကုဋေ
-၁၀.၅၃ ကုဋေ
-၁၀.၂၃ ကုဋေ
-၁၁.၀၇ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၁.၁၅
-၁.၃၁
-၁.၁၇
-၁.၁၁
Interest and investment income
၆.၂၁ သန်း
၅.၃၄ သန်း
၆.၉၁ သန်း
၁.၂၁ ကုဋေ
Interest expense
-
-
-
-
Net interest expenses
၆.၂၁ သန်း
၅.၃၄ သန်း
၆.၉၁ သန်း
၁.၂၁ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
-၉.၅၇ ကုဋေ
-၁၀.၉၂ ကုဋေ
-၁၁.၁၇ ကုဋေ
-၁၂.၂၆ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ